Olcegepant
Chemical compound
From Wikipedia, the free encyclopedia
Olcegepant (INN,[1] code name BIBN-4096BS) is a calcitonin gene-related peptide receptor antagonist being studied as a potential treatment for migraines.[2]
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C38H47Br2N9O5 |
| Molar mass | 869.660 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
A 2013 meta-analysis found olcegepant and telcagepant were effective and safe compared to placebo.[3]